Cigna Group (CI) — Company

Price

Revenue (FY2025) $274.90B

Revenue growth 11.2%

Gross margin 21.8%

Operating margin 3.3%

Net margin 2.2%

Free cash flow —

Website thecignagroup.com

SEC EDGAR All filings →

Financials

Annual · FY2025 · source: SEC EDGAR

Revenue

Net income

Free cash flow

EPS

Income statement	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020
Revenue	$274.90B	$247.12B	$195.26B	$180.52B	$174.07B	$160.40B
Cost of revenue	$214.99B	$182.51B	$133.80B	$124.83B	$117.55B	$103.48B
Gross margin	21.8%	26.1%	31.5%	30.8%	32.5%	35.5%
SG&A	$14.62B	$14.84B	$14.82B	$13.17B	$13.01B	$14.07B
Operating income	$9.20B	$9.42B	$8.54B	$8.45B	$7.94B	$8.15B
Operating margin	3.3%	3.8%	4.4%	4.7%	4.6%	5.1%
Pretax income	$7.78B	$5.27B	$5.51B	$8.40B	$6.79B	$10.87B
Income tax	$1.49B	$1.49B	$141.0M	$1.61B	$1.37B	$2.38B
Net income	$5.96B	$3.43B	$5.16B	$6.78B	$5.42B	$8.49B
Net margin	2.2%	1.4%	2.6%	3.8%	3.1%	5.3%
EPS (diluted)	$22.18	$12.12	$17.39	$21.41	$15.75	$22.96
EPS (basic)	$22.33	$12.25	$17.57	$21.66	$15.89	$23.17
Shares (diluted)	268.6M	283.2M	296.9M	313.1M	341.0M	368.4M

Balance sheet	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020
Total assets	$157.92B	$155.88B	$152.76B	$143.88B	$154.89B	$155.45B
Cash & equivalents	$7.68B	$7.55B	$7.82B	$5.92B	$5.08B	$10.18B
Total liabilities	$116.05B	$114.64B	$106.41B	$99.13B	$107.70B	$105.06B
Stockholders' equity	$41.71B	$41.03B	$46.22B	$44.67B	$47.11B	$50.32B

Cash flow	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020
Operating cash flow	$9.60B	$10.36B	$11.81B	$8.66B	$7.19B	$10.35B

Income statement	TTM	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24	Q2 FY24
Revenue	$277.89B	$68.49B	$72.47B	$69.75B	$67.18B	$65.50B	$65.65B	$63.69B	$60.52B
Cost of revenue	$220.69B	$54.10B	$57.80B	$55.53B	$53.27B	$48.40B	$49.02B	$47.56B	$44.49B
Gross margin	20.6%	21.0%	20.3%	20.4%	20.7%	26.1%	25.3%	25.3%	26.5%
SG&A	$14.13B	$3.72B	$3.61B	$3.36B	$3.43B	$4.21B	$3.87B	$3.59B	$3.68B
Operating income	$9.59B	$2.36B	$2.35B	$2.58B	$2.31B	$1.97B	$2.17B	$2.58B	$2.41B
Operating margin	3.4%	3.4%	3.2%	3.7%	3.4%	3.0%	3.3%	4.0%	4.0%
Pretax income	$8.40B	$2.27B	$1.82B	$2.29B	$2.02B	$1.65B	$2.01B	$1.19B	$1.99B
Income tax	$1.66B	$409.0M	$543.0M	$322.0M	$389.0M	$239.0M	$473.0M	$367.0M	$360.0M
Net income	$6.20B	$1.65B	$943.0M	$1.97B	$1.63B	$1.32B	$1.19B	$825.0M	$1.63B
Net margin	2.2%	2.4%	1.3%	2.8%	2.4%	2.0%	1.8%	1.3%	2.7%
EPS (diluted)	$23.61	$6.26	$4.66	$6.98	$5.71	$4.85	$5.07	$2.63	$5.45
EPS (basic)	$23.76	$6.30	$4.68	$7.02	$5.76	$4.88	$5.12	$2.65	$5.51
Shares (diluted)	266.3M	264.0M	265.7M	267.5M	268.2M	273.0M	277.7M	281.4M	284.1M

Cash flow	TTM	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24	Q2 FY24
Operating cash flow	$8.81B	$1.13B	$6.15B	$3.42B	-$1.89B	$1.92B	$5.21B	$46.0M	$265.0M

Ratios & metrics

source: SEC EDGAR · quarterly on a trailing-twelve-month basis

Profitability	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020
Gross margin	21.8%	26.1%	31.5%	30.8%	32.5%	35.5%
Operating margin	3.3%	3.8%	4.4%	4.7%	4.6%	5.1%
EBITDA margin	4.4%	4.9%	5.9%	6.3%	6.2%	6.8%
Net margin	2.2%	1.4%	2.6%	3.8%	3.1%	5.3%

Returns	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020
Return on equity	14.3%	8.4%	11.2%	15.2%	11.5%	16.9%
Return on assets	3.8%	2.2%	3.4%	4.7%	3.5%	5.5%
Return on invested capital	11.3%	10.3%	12.0%	9.8%	8.4%	8.7%
Return on capital employed	9.1%	9.6%	8.2%	8.2%	7.1%	6.8%

Liquidity	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020
Current ratio	0.85	0.84	0.77	0.73	0.83	0.77
Quick ratio	0.72	0.73	0.65	0.61	0.74	0.68
Cash ratio	0.14	0.13	0.16	0.14	0.12	0.28
Working capital	-$8.53B	-$9.11B	-$11.37B	-$11.10B	-$7.44B	-$8.22B

Leverage	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020
Debt to equity	0.76	0.78	0.67	0.70	0.72	0.65
Debt to assets	0.20	0.21	0.20	0.22	0.22	0.21
Net debt	$23.83B	$24.46B	$23.15B	$25.20B	$28.61B	$22.75B
Net debt / EBITDA	1.99	2.01	2.00	2.21	2.63	2.08
Financial leverage	3.79	3.80	3.30	3.22	3.29	3.09

Efficiency	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020
Asset turnover	1.74	1.59	1.28	1.25	1.12	1.03
Inventory turnover	29.30	27.27	23.70	26.13	31.58	32.70
Receivables turnover	9.56	10.20	11.02	10.48	11.55	13.16
Days sales outstanding	38 days	36 days	33 days	35 days	32 days	28 days
Days inventory outstanding	12 days	13 days	15 days	14 days	12 days	11 days
Days payables outstanding	18 days	19 days	23 days	23 days	21 days	19 days

Cash flow	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020
Income quality (CFO / net income)	1.61	3.02	2.29	1.28	1.33	1.22

Per share	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020
Revenue per share	$1023.60	$872.55	$657.72	$576.62	$510.52	$435.41
Book value per share	$155.32	$144.88	$155.69	$142.70	$138.17	$136.60
Cash per share	$28.58	$26.66	$26.35	$18.92	$14.90	$27.64

Growth	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020
Revenue growth (YoY)	11.2%	26.6%	8.2%	3.7%	8.5%	—
Net income growth (YoY)	73.5%	-33.5%	-23.9%	25.1%	-36.2%	—
EPS growth (YoY)	82.3%	-30.3%	-18.9%	36.3%	-31.4%	—

Profitability	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24	Q2 FY24
Gross margin	20.6%	21.8%	23.1%	24.3%	25.8%	26.1%	27.4%	29.0%
Operating margin	3.4%	3.3%	3.4%	3.4%	3.6%	3.8%	4.0%	4.1%
EBITDA margin	4.4%	4.4%	4.4%	4.5%	4.6%	4.9%	5.2%	5.5%
Net margin	2.2%	2.1%	2.3%	1.9%	1.9%	1.4%	1.4%	1.7%

Returns	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24	Q2 FY24
Return on equity	14.7%	14.1%	14.6%	12.4%	12.4%	8.4%	7.5%	9.1%
Return on assets	4.0%	3.7%	3.9%	3.3%	3.3%	2.2%	2.0%	2.4%
Return on invested capital	11.6%	11.3%	10.6%	10.6%	11.6%	10.3%	13.1%	13.1%
Return on capital employed	9.5%	9.1%	8.9%	9.5%	9.6%	9.6%	9.3%	9.0%

Liquidity	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24	Q2 FY24
Current ratio	0.82	0.85	0.83	0.79	0.78	0.84	0.86	0.83
Quick ratio	0.71	0.72	0.73	0.68	0.69	0.73	0.77	0.74
Cash ratio	0.13	0.14	0.11	0.08	0.15	0.13	0.10	0.12
Working capital	-$9.57B	-$8.53B	-$9.72B	-$12.06B	-$12.19B	-$9.11B	-$7.84B	-$9.16B

Leverage	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24	Q2 FY24
Debt to equity	0.73	0.76	0.81	0.77	0.76	0.78	0.78	0.77
Debt to assets	0.20	0.20	0.22	0.20	0.20	0.21	0.21	0.21
Net debt	$23.86B	$23.83B	$28.02B	$26.44B	$22.11B	$24.46B	$26.91B	$25.10B
Net debt / EBITDA	1.93	1.99	2.39	2.26	1.87	2.01	2.21	2.10
Financial leverage	3.63	3.79	3.78	3.77	3.75	3.80	3.74	3.76

Efficiency	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24	Q2 FY24
Asset turnover	1.81	1.74	1.70	1.73	1.70	1.59	1.48	1.40
Inventory turnover	37.85	29.30	36.62	33.22	36.61	27.27	33.20	29.93
Receivables turnover	10.44	9.56	8.45	8.41	9.48	10.20	8.35	8.68
Days sales outstanding	35 days	38 days	43 days	43 days	38 days	36 days	44 days	42 days
Days inventory outstanding	10 days	12 days	10 days	11 days	10 days	13 days	11 days	12 days
Days payables outstanding	16 days	18 days	17 days	18 days	18 days	19 days	18 days	22 days

Cash flow	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24	Q2 FY24
Income quality (CFO / net income)	1.42	1.64	1.42	1.06	1.50	3.02	2.11	2.50

Per share	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24	Q2 FY24
Revenue per share	$1043.36	$1023.54	$987.04	$952.60	$915.18	$875.03	$811.50	$750.10
Book value per share	$158.48	$155.31	$153.92	$146.20	$144.16	$145.29	$146.87	$142.26
Cash per share	$26.43	$28.58	$22.18	$15.74	$29.87	$26.73	$20.54	$23.36

Growth	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24	Q2 FY24
Revenue growth (YoY)	8.8%	11.2%	15.3%	20.2%	24.0%	26.6%	22.5%	17.1%
Net income growth (YoY)	24.8%	71.0%	94.8%	32.1%	36.3%	-33.5%	-42.8%	-44.8%
EPS growth (YoY)	30.8%	81.5%	112.3%	43.0%	47.4%	-29.9%	-40.6%	-42.4%

What does Cigna Group do?

Visit website →

Cigna Group is a global health company serving more than 185 million customer relationships across more than 30 markets. It operates through two main segments: Evernorth Health Services and Cigna Healthcare. Evernorth Health Services provides pharmacy benefit services and specialty care solutions, including drug claim adjudication, pharmacy network administration, drug utilization review, and formulary management. Cigna Healthcare offers comprehensive medical benefits and coordinated health solutions through its U.S. and International Health operations. Together, these segments combine pharmacy and medical capabilities to deliver solutions focused on improving affordability, transparency, and health outcomes for customers and patients.

Insider transactions · CI

Date	Insider	Role	Type	Shares	Price	Value
Jun 12, 2026	Kates Jamie G	Chief Accounting Officer	Option exercise	899	$152.89	$137,452
Jun 12, 2026	Kates Jamie G	Chief Accounting Officer	Sell	899	$298.61	$268,452
Jun 12, 2026	Kates Jamie G	Chief Accounting Officer	Option exercise	899	—	—
Jun 1, 2026	Koka Durga Prasad	EVP, Global CIO	Tax withholding	729	$275.53	$200,861
May 29, 2026	Kurian George	Director	Grant	108	$277.40	$30,001
May 13, 2026	Cordani David	Chairman & CEO · Director	Option exercise	15,458	$149.14	$2M
May 13, 2026	Cordani David	Chairman & CEO · Director	Option exercise	7,971	$197.35	$2M
May 13, 2026	Cordani David	Chairman & CEO · Director	Option exercise	15,458	—	—
May 13, 2026	Cordani David	Chairman & CEO · Director	Option exercise	7,971	—	—
May 12, 2026	Cordani David	Chairman & CEO · Director	Option exercise	103,595	$149.14	$15M
May 12, 2026	Cordani David	Chairman & CEO · Director	Option exercise	85,519	$197.35	$17M
May 12, 2026	Cordani David	Chairman & CEO · Director	Sell	3,903	$286.83	$1M
May 12, 2026	Cordani David	Chairman & CEO · Director	Sell	14,292	$287.96	$4M
May 12, 2026	Cordani David	Chairman & CEO · Director	Sell	13,839	$288.85	$4M
May 12, 2026	Cordani David	Chairman & CEO · Director	Sell	41,099	$290.00	$12M

See every insider trade on CI — unlock with MLQ Pro →

Source: SEC Form 4. Grants, gifts and option exercises show no market value.

Institutional ownership · CI

85 institutional holders · $290M · 13F, Jun 2026

Holder	Shares	Value
Maj Invest Holding A/S	443,993	$122M
Wilsey Asset Management Inc	123,645	$34M
Assenagon Asset Management S.A.	103,683	$29M
Pensiondanmark Pensionsforsikringsaktieselskab	82,261	$23M
Czech National Bank	75,296	$21M
Cx Institutional	33,831	$9M
Bdf-Gestion	5,270	$6M
Hall Laurie J Trustee	12,523	$3M
Canandaigua National Bank & Trust Co	11,258	$3M
Cmh Wealth Management Llc	9,814	$3M
Red Spruce Capital, Llc	9,721	$3M
Chesley Taft & Associates Llc	8,669	$2M
Gamma Investing Llc	8,100	$2M
Castle Rock Wealth Management, Llc	6,023	$2M
Central Pacific Bank - Trust Division	5,269	$1M
Bath Savings Trust Co	5,237	$1M
Cgn Advisors Llc	4,745	$1M
Wynn Capital, Llc	3,784	$1M
Everhart Financial Group, Inc.	3,641	$1M
American State Bank (Iowa)	3,511	$967,912

See all 85 institutional holders — unlock with MLQ Pro →

Source: SEC Form 13F (latest reported quarter; managers file up to 45 days after quarter-end).

More metrics

Income statement

Revenue → Gross Profit → Operating Income → Net Income → Operating Cash Flow →

Balance sheet

Total Assets → Cash on Hand → Shares Outstanding → Earnings per Share →

Profitability

Gross Margin → Operating Margin → EBITDA Margin → Net Profit Margin → Profitability →

Returns

Return on Equity → Return on Assets → Return on Invested Capital → Return on Capital Employed → Returns →

Liquidity

Current Ratio → Quick Ratio → Cash Ratio → Liquidity →

Leverage & solvency

Debt to Equity → Debt to Assets → Net Debt / EBITDA → Interest Coverage → Solvency & Leverage →

Efficiency

Asset Turnover → Inventory Turnover → Efficiency →

Per share & growth

Revenue per Share → Book Value per Share → Per-Share Metrics → Growth →

MLQ.ai Featured on CI

MLQ.ai Jul 07, 2026

Samsung Heavy Industries Targets Q2 2028 for Floating Data Center Commercialization

Samsung Heavy Industries is targeting Q2 2028 to commercialize its floating data center (FDC) platform, leveraging its shipbuilding scale to address land, power, and cooling constraints facing AI infrastructure. The…

MLQ.ai Jun 30, 2026

Taiwan Raids Super Micro Offices in Widening $2.5B Nvidia Chip Smuggling Probe

Taiwanese prosecutors raided Super Micro Computer's local offices on June 29 as part of a widening probe into an alleged $2.5 billion scheme to smuggle Nvidia AI chips to China through forged documents and…

MLQ.ai Jun 24, 2026

Argentum AI Announces $4.1B Cloud Contract Covering 27,000 Nvidia GB300 GPUs

Argentum AI has announced a $4.1 billion AI cloud contract to deliver approximately 27,000 Nvidia GB300 GPUs to an unnamed customer. The deal adds to the startup's rapidly growing contract book, which includes a…

MLQ.ai Jun 23, 2026

Nvidia's Rubin Data Center Design Eliminates Water Cooling, Saving 2.6 Million Gallons Per MW Annually

Nvidia has released a reference design for its Rubin-generation AI data centers that uses 100% liquid cooling in a closed loop, eliminating the evaporative water consumption that has drawn public backlash against AI…

MLQ.ai Jun 22, 2026

Super Micro Surges 17% on Nvidia Vera Rubin Partnership and Analyst Upgrade

Super Micro Computer shares surged 17% on June 22 after the company unveiled a new AI data center platform built on Nvidia's Vera Rubin NVL4 architecture at ISC 2026 in Hamburg. GF Securities simultaneously upgraded…

SEC filings 186 total · EDGAR

Financials 30

10-Q	Quarterly report · Mar 31, 2026	Apr 30, 2026	Read →
10-K	Annual report · Dec 31, 2025	Feb 26, 2026	Read →
10-Q	Quarterly report · Sep 30, 2025	Oct 30, 2025	Read →
10-Q	Quarterly report · Jun 30, 2025	Jul 31, 2025	Read →
10-Q	Quarterly report · Mar 31, 2025	May 02, 2025	Read →
10-K	Annual report · Dec 31, 2024	Feb 27, 2025	Read →
10-Q	Quarterly report · Sep 30, 2024	Oct 31, 2024	Read →
10-Q	Quarterly report · Jun 30, 2024	Aug 01, 2024	Read →

+22 more financials

Current reports 133

8-K	Current report · Items 7.01 · May 13, 2026	May 13, 2026	Read →
8-K	Current report · Items 2.02,9.01 · Apr 30, 2026	Apr 30, 2026	Read →
8-K	Current report · Items 5.07 · Apr 22, 2026	Apr 27, 2026	Read →
8-K	Current report · Items 5.02,7.01,9.01 · Feb 25, 2026	Mar 03, 2026	Read →
8-K	Current report · Items 7.01 · Feb 27, 2026	Feb 27, 2026	Read →
8-K	Current report · Items 2.02,9.01 · Feb 05, 2026	Feb 05, 2026	Read →
8-K	Current report · Items 8.01 · Oct 22, 2025	Nov 18, 2025	Read →
8-K	Current report · Items 2.02,9.01 · Oct 30, 2025	Oct 30, 2025	Read →

+125 more current reports

Prospectuses & registrations 6

424B5	Prospectus	Sep 04, 2025	Read →
424B5	Prospectus	Sep 02, 2025	Read →
424B5	Prospectus	Feb 07, 2024	Read →
424B5	Prospectus	Mar 02, 2023	Read →
424B5	Prospectus	Mar 03, 2021	Read →
424B5	Prospectus	Mar 05, 2020	Read →

Proxies 8

DEF 14A	Proxy statement · Apr 22, 2026	Mar 13, 2026	Read →
DEF 14A	Proxy statement · Apr 23, 2025	Mar 14, 2025	Read →
DEF 14A	Proxy statement · Apr 24, 2024	Mar 15, 2024	Read →
DEF 14A	Proxy statement	Mar 17, 2023	Read →
DEF 14A	Proxy statement · Apr 27, 2022	Mar 18, 2022	Read →
DEF 14A	Proxy statement · Apr 28, 2021	Mar 19, 2021	Read →
DEF 14A	Proxy statement · Apr 22, 2020	Mar 13, 2020	Read →
DEF 14A	Proxy statement · Apr 24, 2019	Mar 15, 2019	Read →

Ownership 9

SC 13G	Beneficial ownership (13G)	Nov 12, 2024	Read →
SC 13G	Beneficial ownership (13G)	Feb 09, 2023	Read →
SC 13G	Beneficial ownership (13G)	Feb 07, 2023	Read →
SC 13G	Beneficial ownership (13G)	Feb 14, 2022	Read →
SC 13G	Beneficial ownership (13G)	Feb 08, 2021	Read →
SC 13G	Beneficial ownership (13G)	Feb 14, 2020	Read →
SC 13G	Beneficial ownership (13G)	Feb 14, 2019	Read →
SC 13G	Beneficial ownership (13G)	Feb 14, 2019	Read →

+1 more ownership

Form	Description	Filed	Link
8-K	Current report · Items 7.01	May 13, 2026	Read → SEC ↗
10-Q	Quarterly report	Apr 30, 2026	Read → SEC ↗
8-K	Current report · Items 2.02,9.01	Apr 30, 2026	Read → SEC ↗
8-K	Current report · Items 5.07	Apr 27, 2026	Read → SEC ↗
DEF 14A	Proxy statement	Mar 13, 2026	Read → SEC ↗
8-K	Current report · Items 5.02,7.01,9.01	Mar 03, 2026	Read → SEC ↗
8-K	Current report · Items 7.01	Feb 27, 2026	Read → SEC ↗
10-K	Annual report	Feb 26, 2026	Read → SEC ↗
8-K	Current report · Items 2.02,9.01	Feb 05, 2026	Read → SEC ↗
8-K	Current report · Items 8.01	Nov 18, 2025	Read → SEC ↗
10-Q	Quarterly report	Oct 30, 2025	Read → SEC ↗
8-K	Current report · Items 2.02,9.01	Oct 30, 2025	Read → SEC ↗
8-K	Current report · Items 5.02	Oct 20, 2025	Read → SEC ↗
8-K	Current report · Items 1.01,2.03,8.01,9.01	Sep 04, 2025	Read → SEC ↗
424B5	Prospectus	Sep 04, 2025	Read → SEC ↗
424B5	Prospectus	Sep 02, 2025	Read → SEC ↗
8-K	Current report · Items 7.01	Sep 02, 2025	Read → SEC ↗
10-Q	Quarterly report	Jul 31, 2025	Read → SEC ↗
8-K	Current report · Items 2.02,9.01	Jul 31, 2025	Read → SEC ↗
8-K/A	Current report (amended) · Items 5.02	Jul 28, 2025	Read → SEC ↗
8-K	Current report · Items 5.02,9.01	Jun 02, 2025	Read → SEC ↗
8-K	Current report · Items 7.01	May 20, 2025	Read → SEC ↗
10-Q	Quarterly report	May 02, 2025	Read → SEC ↗
8-K	Current report · Items 2.02,9.01	May 02, 2025	Read → SEC ↗
8-K	Current report · Items 1.01,1.02,2.03,5.02,5.07	Apr 28, 2025	Read → SEC ↗
8-K	Current report · Items 5.02	Apr 18, 2025	Read → SEC ↗
8-K	Current report · Items 8.01,9.01	Mar 19, 2025	Read → SEC ↗
DEF 14A	Proxy statement	Mar 14, 2025	Read → SEC ↗
8-K	Current report · Items 5.02,7.01	Mar 13, 2025	Read → SEC ↗
8-K	Current report · Items 7.01	Mar 03, 2025	Read → SEC ↗
10-K	Annual report	Feb 27, 2025	Read → SEC ↗
8-K	Current report · Items 2.02,9.01	Jan 30, 2025	Read → SEC ↗
SC 13G	Beneficial ownership (13G)	Nov 12, 2024	Read → SEC ↗
10-Q	Quarterly report	Oct 31, 2024	Read → SEC ↗
8-K	Current report · Items 2.02,9.01	Oct 31, 2024	Read → SEC ↗
8-K	Current report · Items 7.01	Sep 03, 2024	Read → SEC ↗
10-Q	Quarterly report	Aug 01, 2024	Read → SEC ↗
8-K	Current report · Items 2.02,9.01	Aug 01, 2024	Read → SEC ↗
8-K	Current report · Items 5.02	Jun 20, 2024	Read → SEC ↗
8-K	Current report · Items 7.01	Jun 06, 2024	Read → SEC ↗
10-Q	Quarterly report	May 02, 2024	Read → SEC ↗
8-K	Current report · Items 2.02,9.01	May 02, 2024	Read → SEC ↗
8-K	Current report · Items 5.07	Apr 26, 2024	Read → SEC ↗
8-K	Current report · Items 1.01,2.03,8.01	Apr 26, 2024	Read → SEC ↗
DEF 14A	Proxy statement	Mar 15, 2024	Read → SEC ↗
8-K	Current report · Items 7.01,9.01	Mar 07, 2024	Read → SEC ↗
10-K	Annual report	Feb 29, 2024	Read → SEC ↗
8-K	Current report · Items 8.01,9.01	Feb 15, 2024	Read → SEC ↗
8-K	Current report · Items 1.01,2.03,7.01,8.01,9.01	Feb 13, 2024	Read → SEC ↗
8-K	Current report · Items 8.01,9.01	Feb 07, 2024	Read → SEC ↗

186 filings on file — see every 10-K, 10-Q, 8-K and proxy. Unlock with MLQ Pro →

Contacts at Cigna Group

thecignagroup.com

🔒

Contacts are a premium feature

Upgrade to MLQ.ai premium to search verified business contacts at Cigna Group by department, seniority, and role.

Upgrade to premium